Literature DB >> 28516198

[Local consolidative therapy improves progression-free survival in patients with oligometastatic NSCLC : Results of a randomized phase II study].

Tobias Finazzi1, Matthias Guckenberger2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28516198     DOI： 10.1007/s00066-017-1147-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

1.  Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.

Authors:  Stephen L Lewis; Sandro Porceddu; Naoki Nakamura; David A Palma; Simon S Lo; Peter Hoskin; Drew Moghanaki; Steven J Chmura; Joseph K Salama
Journal:  Am J Clin Oncol       Date:  2017-08       Impact factor: 2.339

2.  Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.

Authors:  Puneeth Iyengar; Brian D Kavanagh; Zabi Wardak; Irma Smith; Chul Ahn; David E Gerber; Jonathan Dowell; Randall Hughes; Ramzi Abdulrahman; D Ross Camidge; Laurie E Gaspar; Robert C Doebele; Paul A Bunn; Hak Choy; Robert Timmerman
Journal:  J Clin Oncol       Date:  2014-10-27       Impact factor: 44.544

3.  Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.

Authors:  Juliane Rieber; Nasrin Abbassi-Senger; Sonja Adebahr; Nicolaus Andratschke; Oliver Blanck; Marciana Duma; Michael J Eble; Iris Ernst; Michael Flentje; Sabine Gerum; Peter Hass; Christoph Henkenberens; Guido Hildebrandt; Detlef Imhoff; Henning Kahl; Nathalie Desirée Klass; Robert Krempien; Fabian Lohaus; Frank Lohr; Cordula Petersen; Elsge Schrade; Jan Streblow; Lorenz Uhlmann; Andrea Wittig; Florian Sterzing; Matthias Guckenberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-26       Impact factor: 7.038

4.  Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience.

Authors:  Maria Teresa Congedo; Alfredo Cesario; Filippo Lococo; Chiara De Waure; Giovanni Apolone; Elisa Meacci; Sergio Cavuto; Pierluigi Granone
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-17       Impact factor: 5.209

5.  Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?

Authors:  Joachim Widder; Theo J Klinkenberg; Jan F Ubbels; Erwin M Wiegman; Harry J M Groen; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2013-06-14       Impact factor: 6.280

6.  Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).

Authors:  Dirk De Ruysscher; Rinus Wanders; Angela van Baardwijk; Anne-Marie C Dingemans; Bart Reymen; Ruud Houben; Gerben Bootsma; Cordula Pitz; Linda van Eijsden; Wiel Geraedts; Brigitta G Baumert; Philippe Lambin
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

Review 7.  An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Authors:  Allison B Ashworth; Suresh Senan; David A Palma; Marc Riquet; Yong Chan Ahn; Umberto Ricardi; Maria T Congedo; Daniel R Gomez; Gavin M Wright; Giulio Melloni; Michael T Milano; Claudio V Sole; Tommaso M De Pas; Dennis L Carter; Andrew J Warner; George B Rodrigues
Journal:  Clin Lung Cancer       Date:  2014-05-15       Impact factor: 4.785

8.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

9.  A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis.

Authors:  Robert J Downey; Kenneth K Ng; Mark G Kris; Manjit S Bains; Vincent A Miller; Robert Heelan; Mark Bilsky; Robert Ginsberg; Valerie W Rusch
Journal:  Lung Cancer       Date:  2002-11       Impact factor: 5.705

10.  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Authors:  Daniel R Gomez; George R Blumenschein; J Jack Lee; Mike Hernandez; Rong Ye; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Chad Tang; Ritsuko Komaki; Alexander V Louie; David A Palma; Anne S Tsao; Boris Sepesi; William N William; Jianjun Zhang; Qiuling Shi; Xin Shelley Wang; Stephen G Swisher; John V Heymach
Journal:  Lancet Oncol       Date:  2016-10-24       Impact factor: 41.316
View more
  1 in total

1.  Use of psychosocial services by lung cancer survivors in Germany : Results of a German multicenter study (LARIS).

Authors:  Martin Eichler; Marlene Hechtner; Beatrice Wehler; Roland Buhl; Jan Stratmann; Martin Sebastian; Heinz Schmidberger; Cornelius Kortsik; Ursula Nestle; Hubert Wirtz; Thomas Wehler; Maria Blettner; Susanne Singer
Journal:  Strahlenther Onkol       Date:  2019-07-10       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.